Bescot seeks to purchase pharmaceutical products nearing the end of their lifecycle, from larger pharmaceutical companies with a view to maintaining ongoing access to the products for Canadians. Bescot is also looking to partner with companies from outside Canada to introduce their innovative products into Canada, either acting as a “contract Executive Management Team” (cEMT), or as the exclusive distributor. Bescot has a therapeutic focus on Diabetes related cardiovascular outcomes, Women’s Health Care and Oncology, and is currently the exclusive Canadian distributor for a number of key products in these areas